Chamuleau, Martine E D; Stenner, Frank; Chitu, Dana A; Novak, Urban; Minnema, Monique C; Geerts, Paul; Stevens, Wendy B C; Zenz, Thorsten; van Imhoff, Gustaaf W; Wu, Ka Lung; Demandt, Astrid M P; Kersten, Marie Jose; Terpstra, Wim E; Tick, Lidwine W; Deeren, Dries; Van Den Neste, Eric; Gregor, Michael; Veelken, Hendrik; Böhmer, Lara H; Caspar, Clemens B; Mutsaers, Pim; Refos, Jeannine M; Sewsaran, Robby; Fu, Liping; Seefat, Rianne L; Uyl-de Groot, Carin A; Dirnhofer, Stefan; Van Den Brand, Michiel; de Jong, Daphne; Nijland, Marcel; Lugtenburg, Pieternella
(Lancet Publishing Group, 2023-12)
BACKGROUND: Patients with newly diagnosed high-risk Burkitt lymphoma are treated with high-intensity immune-chemotherapy regimens such as R-CODOX-M/R-IVAC or with lower-intensity regimens such as DA-EPOCH-R. The aim of ...